Cart
sales@molnova.com
Ozagrel
CAS No. 82571-53-7
Ozagrel( OKY-046 )
Catalog No. M16065 CAS No. 82571-53-7
Ozagrel is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor with IC50 of 11 nM for rabbit platelet.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 29 | Get Quote |
|
| 10MG | 47 | Get Quote |
|
| 25MG | 77 | Get Quote |
|
| 50MG | 109 | Get Quote |
|
| 100MG | 164 | Get Quote |
|
| 200MG | 212 | Get Quote |
|
| 500MG | 356 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameOzagrel
-
NoteResearch use only, not for human use.
-
Brief DescriptionOzagrel is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor with IC50 of 11 nM for rabbit platelet.
-
DescriptionOzagrel is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor with IC50 of 11 nM for rabbit platelet, used for the improvement of postoperative cerebrovascular contraction and accompanying cerebral ischaemia.
-
In Vitro——
-
In Vivo——
-
SynonymsOKY-046
-
PathwayAutophagy
-
TargetThrombin
-
RecptorThromboxane A2 synthetase
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number82571-53-7
-
Formula Weight228.25
-
Molecular FormulaC13H12N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 46 mg/mL (201.53 mM)
-
SMILESC1=CC(=CC=C1CN2C=CN=C2)/C=C/C(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ishitsuka Y, et al. J Pharmacol Sci, 2009, 111(2), 211-215.
molnova catalog
related products
-
Protamine sulfate
Protamine sulfate is a polycationic peptide that serves as an antiheparin agent. This compound can neutralize the anticoagulant action of heparin and enhance lipid-mediated gene transfer.
-
Ozagrel
Ozagrel is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor with IC50 of 11 nM for rabbit platelet.
-
Imitrodast
Imitrodast is a small molecule thromboxane A2 synthase (TXA2 synthase) inhibitor for the treatment of immune system disorders, respiratory disorders, and cardiovascular diseases, and can be used in studies of arterial thrombosis, asthma, and coronary vasospasm.
